Is HbA1c a good screening test for diabetes mellitus?

Clinical Biochemistry

Volumn 44, Issue 17-18, 2011, Pages 1469-1472

  Higgins, Trefor N ^a   Tran, David ^b   Cembrowski, George S ^b   Shalapay, Carol ^b   Steele, Pamela ^c   Wiley, Carmen ^d  

^a University of Alberta Hospital ^*

^b UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^c MARSHFIELD CLINIC   (United States)

^d SACRED HEART MEDICAL CENTER   (United States)

Author keywords

Diabetes mellitus; Diagnosis; Oral glucose tolerance test; Predictive values

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ARTICLE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCREENING TEST; AGED; BLOOD; CLINICAL TRIAL; GLUCOSE TOLERANCE TEST; METABOLISM; MIDDLE AGED; MULTICENTER STUDY;

ADULT; AGED; DIABETES MELLITUS; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; ROC CURVE;

EID: 81555228651     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.08.1138     Document Type: Article

References (22)

1. Berg A.H., Sacks D.B. Haemoglobin A1c analysis in the management of patients with diabetes; from chaos to harmony. J Clin Pathol 2007, 61:983-987.
2. Kilpatrick E.S. Haemoglobin A1c in the diagnosis and monitoring of diabetes mellitus. J Clin Pathol 2008, 61:977-982.
3. Sacks D.B., Bruns D.E., Golstein D.E., Maclaren N.K., McDonald J.M., Parrot M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002, 48:436-472.
4. Wilson S.E., Lipscombe L.L., Rosetta L.C., Manuel D.G. Trends in laboratory testing for diabetes in Ontario, Canada 1995-2005: a population-based study. BMC Health Serv Res 2009, 9:41.
5. 1c to screen for diabetes. J Diabetes Sci Technol 2009, 3:411-417.
6. Saudek C.D., Herman W.H., Sacks D.B., Bergenstal R.M., Edelman D., Davison M.B. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab 2008, 93:2447-2453.
7. International Expert Committee International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care 2009, 32:1327-1334.
8. Professional Practice Committee Standards of medical care in diabetes-2010. Diabetes Care 2010, 33:S11-S61.
9. Sacks D.B. The diagnosis of diabetes is changing; how implementation of hemoglobin A1c will impact clinical laboratories. Clin Chem 2009, 55:1612-1614.
10. Olson D.E., Rhee M.K., Herrick K., Ziemer D.C., Twombly J.G., Phillips L.S. Screening for diabetes and pre-diabetes with the proposed A1C-based diagnostic criteria. Diabetes Care 2010, 33:2184-2189.
11. Selvin E., Ziu H., Brancati F.L. Elevated A!C in adults without a history of diabetes in the U.S. Diabetes Care 2009, 32:828-833.
12. Lorenzo C.L., Wagnkecht L.E., Hanley A.J.G., Rewers M.J., Karter A.J., Haffner S.M. A1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors. Diabetes Care 2010, 33:2104-2107.
13. Canadian Diabetes Association. 2003 Clinical Practice Guidelines for the prevention and management of Diabetes in Canada. Can J Diabetes 2003, 27:S7-S9. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee.
14. Cowie C.C., RustK F., Bryd-Holt D.D., Eberhardt M.S., Flegal M.S., Flegal K.M., Engelgau M.M., et al. Prevalence of diabetes and impaired fasting glucose in the US population: National Health and Nutrition Examination survey 1999-2002. Diabetes Care 2006, 29:1263-1268.
15. Cowie C.C., Rust K.F., Ford E.S., Eberhardt M.S., byrd-Holt D.D., Li C., et al. Full accounting of diabetes and pre-diabetes in the US population in 1988-1994 and 2005-2006. Diabetes Care 2009, 32:287-294.
16. Rohlfing C.L., Wiedmeyer H.-M., Little R.R., England J.D., Tennill A., Goldstein D. Biological variation of glycohemoglobin. Clin Chem 2002, 48:1116-1118.
17. Phillipou G., Phillips P.J. Intraindividual variation of glycohemoglobin; implications for interpretation and analytical goals. Clin Chem 1993, 39:2305-2308.
18. Kilpatrick E.S., Maylor P.W., Keevil B.G. Biological variation of glycated hemoglobin. Implications for diabetes screening and monitoring. Diabetes Care 1998, 21:261-264.
19. Braga F., Dolci A., Mosca A., Panteghini M. Biological variability of glycated hemoglobin. Clin Chem Acta 2010, 411:1606-1610.
20. 1c point-of-care instruments do not meet the general accepted analytical performance criteria. Clin Chem 2010, 56:44-52.
21. Bruns D.E., Knowler W.C. Stabilization of glucose in blood samples: why it matters. Clin Chem 2009, 55:850.
22. Colapinto C.K., O'Connor D.L., Tremblay M.S. Folate status of the population in the Canadian Health Measures Survey. CMAJ 2010, 10:1503/cmaj.100568.